Acomplia (Rimonabant) is a new weight loss medication which is manufactured by Sanofi-Aventis, a French drug-maker. Acomplia with Rimonabant as its active ingredient is an effectual appetite suppressant. Rimonabant works by blocking the CB-1 receptors which are responsible for food consumption in the body. When these CB-1 receptors are blocked your normal appetite is decreased and you tend to eat less. This means you eat in smaller portions and lose weight in an effective manner.
This weight loss medication Acomplia (Rimonabant) has been made saleable in the UK, Germany, Sweden, France, Holland, Ireland, Austria amid other European countries. Spain, Italy, Mexico are amongst other prospective countries which are most likely to enjoy the benefits of Acomplia sale in the coming future. Its launch in the US weight loss market has been stalled due to the delay in FDA approval for unspecified reasons.
It should be understood Acomplia Rimonabant is an oral prescription medication, which should be used proper medical supervision. Women planning pregnancy, pregnant women, breast-feeding mothers, heart patients, and diabetics should keep away from intake of Acomplia Rimonabant diet pill without medical guidance. Stick to your doctor’s prescription for effective weight loss results. Inform your doctor about your medical history including any drug or alcohol abuse, as it can prevent unforeseen medical complications.
Buy Acomplia for Europe only € 142.55
Buy Acomlia for USA only $245.00
Apart from weight loss results, Acomplia Rimonabant has other benefits too. In accordance to 2 years of clinical trials, usage of Acomplia Rimonabant medication is also beneficial in smoking cessation, improvement of cardio- metabolic results, and even reduces chances of weight regain. |
